Cargando…

Factors Associated with Appropriate Hepatocellular Carcinoma (HCC) Screening Among Chronic Hepatitis C (HCV) Patients with Cirrhosis at an Urban Safety-net Hospital System

BACKGROUND: Despite guidelines recommending liver ultrasound (US) every 6 months for HCC screening in cirrhotic patients with HCV, reported screening rates remain low. Our study evaluated (1) timely screening among patients with HCV cirrhosis identified by transient elastography (FibroScan [FS]) and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabrera, Nicolo, Burke, Kerianne, Huhn, Gregory, Go, Benjamin, Winston, Crystal, Adeyemi, Oluwatoyin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632172/ http://dx.doi.org/10.1093/ofid/ofx163.377

Ejemplares similares

Steatosis Rates by Liver Biopsy and Transient Elastography With Controlled Attenuation Parameter in Clinical Experience of Hepatitis C Virus (HCV) and Human Immunodeficiency Virus/HCV Coinfection in a Large US Hepatitis Clinic
por: Sansom, Sarah E, et al.
Publicado: (2019)

2208. Fibrosis Surveillance by Transient Elastography in Patients with Untreated Hepatitis C Infection
por: Adeyemi, Oluwatoyin, et al.
Publicado: (2018)

2235. A Collaborative Drug Therapy Management Model for the Treatment of Hepatitis C Virus (HCV) in an Urban Clinic
por: Vibhakar, Sonia, et al.
Publicado: (2018)

2252. Predictors of Cardiovascular Outcomes in Older HIV-Infected Patients: CORE50 Cohort 10-Year Follow-up
por: Sansom, Sarah, et al.
Publicado: (2018)

Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)
por: Zhao, Pin, et al.
Publicado: (2021)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
por: De Battista, Davide, et al.
Publicado: (2021)

Association of C-myc and p53 Gene Expression and Polymorphisms with Hepatitis C (HCV) Chronic Infection, Cirrhosis and Hepatocellular Carcinoma (HCC) Stages in Egypt
por: Koutb, Fayed, et al.
Publicado: (2017)

HCC: RNA-Sequencing in Cirrhosis
por: Wang, Haoyu, et al.
Publicado: (2023)

2213. Hepatitis C Virus (HCV) Care Continuum Post-implementation of Electronic Clinical Decision Support (eCDS) Tool to Increase HCV Screening Among Baby Boomers in Large Urban Health System
por: Armstrong, Hilary, et al.
Publicado: (2018)

Impact of deranged B cell subsets distribution in the development of HCV-related cirrhosis and HCC in type two diabetes mellitus
por: Abdelwahab, Fadwa A., et al.
Publicado: (2020)

Reluctance to Prescribe Pre-Exposure Prophylaxis (PrEP) Among Internal Medicine Residents (IMRs) Training at a U.S. Hospital with a Large HIV-infected Population
por: Martin, Jonathan, et al.
Publicado: (2017)

Carcinovic cohort: prognostic factors of death in HIV/HCV coinfected patients with hepatocellular carcinoma (HCC)
por: Gelu-Simeon, M, et al.
Publicado: (2014)

Aggressive primary gastric lymphoma (PGL) masquerading as hepatocellular cancer (HCC) in alcoholic cirrhosis
por: Ahmed, Moiz, et al.
Publicado: (2021)

576. Continuing Disparities in Virologic Control for People Living with HIV (PLWH) Receiving Care at a Large, Urban, Safety-Net Clinic
por: Lubelchek, Ronald, et al.
Publicado: (2018)

Factors associated with hepatocellular carcinoma occurrence after HCV eradication in patients without cirrhosis or with compensated cirrhosis
por: Abe, Kazumichi, et al.
Publicado: (2020)

Genetic polymorphisms related to the vitamin D pathway in patients with cirrhosis with or without hepatocellular carcinoma (HCC)
por: de Jesus Brait, Beatriz, et al.
Publicado: (2022)

Plasma Protein Biomarkers of Hepatocellular Carcinoma in HCV-Infected Alcoholic Patients with Cirrhosis
por: Ferrín, Gustavo, et al.
Publicado: (2015)

Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison With HBV Infection: A proteomics study
por: Sarvari, Jamal, et al.
Publicado: (2013)

TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis
por: Nomair, Azhar Mohamed, et al.
Publicado: (2021)

Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)

Interleukin-6 polymorphisms in HCC patients chronically infected with HCV
por: Adnan, Faisal, et al.
Publicado: (2020)

CD8(+) T Cell Responses during HCV Infection and HCC
por: Hofmann, Maike, et al.
Publicado: (2021)

A Curious Case of Vanishing Hepatocellular Carcinoma (HCC)
por: Kwei-Nsoro, Robert, et al.
Publicado: (2023)

Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV Cirrhosis
por: Abdel-Hafiz, Samah Mamdouh, et al.
Publicado: (2018)

Cytokeratin-18 in Diagnosis of HCC in Patients with Liver Cirrhosis
por: Ismail, Saber A, et al.
Publicado: (2017)

Diabetes and the risk of cirrhosis and HCC: An analysis of the UK Biobank
por: Ye, Fangzhou, et al.
Publicado: (2023)

351. Neurocysticercosis: Clinical Experience in Large Urban Safety Net Hospital in Chicago
por: Pendyala, Bharath, et al.
Publicado: (2020)

Plasma lipids, tumor parameters and survival in HCC patients with HBV and HCV
por: Akkiz, H, et al.
Publicado: (2020)

Sorafenib in the Treatment of Virus-Related HCC: Differences Between HCV and HBV
por: De Matteis, Serena, et al.
Publicado: (2021)

Problems of Long Survival Following Surgery in Patients with NonBNonC-HCC: Comparison with HBV and HCV Related-HCC
por: Hiwatashi, Kiyokazu, et al.
Publicado: (2015)

Human Hepatocellular Carcinoma (HCC)
por: Buonaguro, Luigi
Publicado: (2020)

Progression of liver cirrhosis to HCC: an application of hidden Markov model
por: Bartolomeo, Nicola, et al.
Publicado: (2011)

1466. Antiretroviral (ART) Virologic Suppression (VS) and Patient Reported Outcomes (PROs) at 6 Months in the Clinical Opportunities and Management to Exploit Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) an Asynchronous Connection Key (COMEBACK) Study
por: Roden, Lindsey, et al.
Publicado: (2022)

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
por: Huang, Yan, et al.
Publicado: (2022)

Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
por: Kotsari, Maria, et al.
Publicado: (2023)

The Burgeoning HIV/HCV Syndemic in the Urban Northeast: HCV, HIV, and HIV/HCV Coinfection in an Urban Setting
por: Morano, Jamie P., et al.
Publicado: (2013)

Efficacy and Safety of Microwave Ablation (MWA) for Hepatocellular Carcinoma (HCC) in Difficult Anatomical Sites in Egyptian Patients with Liver Cirrhosis
por: Soliman, Ahmad F, et al.
Publicado: (2019)

HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation
por: Emamaullee, Juliet A., et al.
Publicado: (2019)

Serum Markers of Epithelial Mesenchymal Transition as Predictors of HCV-induced Liver Fibrosis, Cirrhosis and Hepatocellular Carcinoma
por: Zoheiry, Mona M, et al.
Publicado: (2015)

Risk Factors for Hepatocellular Carcinoma Recurrence and Survival after Liver Transplantation in Patients with HCV-Related Cirrhosis
por: Vidal, Raphael Iglesias de Oliveira, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fp5ktbsmvd1obprdpe2nqs29uo